22 Labtech provides quality technology for healthcare in the Nordic and Baltic countries.
We are a distributor of innovative medical technology products in Finland, Sweden, Norway, Denmark, Iceland, Estonia, Latvia and Lithuania.
Our service to healthcare customers is driven by the key principles of understanding needs and delivering promises.
hema-screen SpecificTM, a Fecal Immunochemical Test (FIT) is a rapid qualitative immunoassay for the specific determination of human hemoglobin in feces, a vital tool in the diagnosis of gastrointestinal disorders.
FebriDx® test combines the interpretation of MxA and CRP into a pattern of results, providing an accurate way to differentiate viral from bacterial infectious etiology at the point of care.